Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04452214
Title A Study of the Safety and Tolerance of CAN04 in Combination With Pembrolizumab in Subjects With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cantargia AB
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Florida Cancer Specialists & Research Institute Lake Mary Florida 32746 United States Details
Hospital of The University of Pennsylvania Philadelphia Pennsylvania 19104-5127 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field